Orangebiomed

Kenya
Kapsokwony, Bungoma County, Kenya

Company profile

Orangebiomed company profile

Orange Biomed is developing "OBM rapid A1c", the world-first reusable and portable HbA1c device for better diabetes management. Orange Biomed's advanced microfluidic technology brings a lab-accurate blood test to patient's home, providing A1c test for anyone, anytime, and anywhere. With only a drop of blood sample, patients can easily monitor their A1c level at home at affordable price, saving time traveling back and forth from doctor's office.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2021-08-09

Headquarters

Country code
KE
Continent
Africa

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
6
Total equity funding
$6.1M
Last funding
Series A / $2.1M / 2024-12-10
Last equity funding
Series A / $2.1M
Investors
3
Lead investors
3
Articles
19

Founders and investors

Lead investors

Digital Healthcare PartnersIntops InvestmentSeoul New Technology Investment Co.

Investors

Digital Healthcare PartnersIntops InvestmentSeoul New Technology Investment Co.